Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gatsios Leaving Healthlinx; New COO at Agilent; and More

Premium

Healthlinx said this week that CEO Nick Gatsios will resign as of June 30, 2012.

Gatsios was a founding director of the company when it launched in 2002 and has been its CEO since it went public on the Australian Stock Exchange in 2006. He is extending his contracted notice period by two months in order “to complete current projects of strategic importance,” the company said.

No reason was given for his departure.


Agilent this week appointed Ron Nersesian executive vice president and chief operating officer.

Prior to the appointment, Nersesian had been president of Agilent’s Electronic Measurement Group.


Sparton Corporation’s board of directors this week named Charles Kummeth an independent director.

Kummeth is president of Thermo Fisher Scientific’s Global Chromatography and Mass Spectrometry division.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.